NCT06864949

Brief Summary

The present study aimed to investigate the cross-sectional effect of Class I AMCOP devices in patients of all possible skeletal types from both vertical skeletal pattern (normodivergent, hyperdivergent, hypodivergent) and sagittal skeletal pattern (skeletal Class I, skeletal Class II, skeletal Class III). The criterion for choosing patients was determined by the protocol of using these devices, which is to always perform an AMCOP First Class phase with the aim of improving transverse coordination of the arches, Spee's Curve and Wilson's Curve.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

March 15, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

February 25, 2025

Last Update Submit

April 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in upper intermolar distance on digital casts

    The upper intermolar distance take as reference the top of the mesiovestibular cusp of the upper first molars.

    Before treatment (T0) and after 10-12 months of treatment (T1)

Secondary Outcomes (15)

  • Change in upper intercanine distance on digital casts

    Before treatment (T0) and after 10-12 months of treatment (T1)

  • Change in lower intercanine distance on digital casts

    Before treatment (T0) and after 10-12 months of treatment (T1)

  • Change in ANB angle

    Before treatment (T0) and after 10-12 months of treatment (T1)

  • Change in Wits Index

    Before treatment (T0) and after 10-12 months of treatment (T1)

  • Change in Skeletal Class

    Before treatment (T0) and after 10-12 months of treatment (T1)

  • +10 more secondary outcomes

Study Arms (1)

Treatment with AMCOP First Class appliance

EXPERIMENTAL
Device: AMCOP appliance

Interventions

The device measure will be determined with OrthoCad program on digital models, taking the distance between the vestibular cusps of the upper first molars, at the level of the most prominent point. AMCOPs are preformed devices and there are five different measures based on transverse diameter: 1 (45mm), 2 (50mm), 3 (55mm), 4 (60mm), 5 (65mm). Requiring expansion, we will choose an higher AMCOP measure than the transverse distance measured on the digital models at T0. The clinical indications for use of the AMCOP device will be as follow: * in the first week, wear the appliance during the night and for 30 minutes during the day * from the second week onward, wear the appliance for one hour during the day and throughout the night During this time, every month we will visit patients and we will expand the device by soaking it in hot water at about 70 °C for 30 s and then in cold water to stabilize it in its new shape.

Treatment with AMCOP First Class appliance

Eligibility Criteria

Age7 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients presenting maxillary transverse deficits (that includes: posterior crossbite monolateral or bilateral; end-to-end occlusal relationships; excessive linguoinclination of lower posterior teeth due to the contraction of maxillary arch; limited permutation space of permanent elements)
  • patients with all sagittal and vertical skeletal patterns

You may not qualify if:

  • syndromic patterns, cleft lip or cleft palate, severe malformations of the maxillae, severe skeletal asymmetry
  • physical or psychological limitations
  • presence of metallic restorations
  • previous orthodontic treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia

Pavia, Lombardy, 27100, Italy

Location

Study Officials

  • Andrea Scribante, DDS, PhD

    University of Pavia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Principal Investigator

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 7, 2025

Study Start

March 15, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Data will be available upon motivated request to the Principal Investigator.

Locations